ViAqua Therapeutics Ltd announced that it has received $4,300,000 in a round of funding on June 9, 2021. The transaction included participation from S2G Ventures, Thai Union Group Public Company Limited (SET:TU), Agriline, existing investors VisVires New Protein, a fund managed by VisVires New Protein Capital Pte. Ltd., The Trendlines Group Ltd. (Catalist:42T), Technion Israel Institute Of Technology, Endowment Arm, and Nutreco Investments B.V.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.066 SGD | -5.71% | -4.35% | -27.47% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.47% | 49.31M | |
+31.41% | 12.02B | |
+12.12% | 3B | |
+1.64% | 1.41B | |
-8.46% | 1.21B | |
+37.82% | 585M | |
-18.59% | 524M | |
-4.17% | 487M | |
+40.22% | 510M | |
+3.90% | 301M |
- Stock Market
- Equities
- 42T Stock
- News The Trendlines Group Ltd.
- ViAqua Therapeutics Ltd announced that it has received $4.3 million in funding from a group of investors